Business & Consumer Services » Shell companies | Profound Medical Corp.

Profound Medical Corp.

Profound Medical Corp.
Stock Exchange Other OTC
EPS
$0.13
Market Cap
$64.83 M
Shares Outstanding
108.04 M
Public Float
-

Profile

Address
2400 Skymark Avenue
Mississauga Ontario L4W 5K5
Canada
Employees -
Website http://www.profoundmedical.com
Updated 07/08/2019
Profound Medical Corp. engages in developing and commercializing minimally invasive treatments for prostate cancer. It develops Transurethral Ultrasound Ablation-PRO system that completed a Phase I clinical trial, which combines magnetic resonance imaging guidance, and ultrasound energy to deliver thermal ablative therapy to the prostate gland delivered through the urethra. Profound Medical was founded in 2008 and is headquartered in Toronto, CA.

Financials

View All

Arun S. Menawat
Chief Executive Officer & Non-Independent Director
Damian Lamb
Chairman